Home/Pipeline/Fast laser device

Fast laser device

Glaucoma IOP reduction

CommercialActive

Key Facts

Indication
Glaucoma IOP reduction
Phase
Commercial
Status
Active
Company

About BioLight

Israel's sole publicly listed ophthalmology‑focused investment platform, BioLight builds a diversified portfolio of innovative eye‑care technologies.

View full company profile

Therapeutic Areas